Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028
As per Triton’s report, Europe’s hormone replacement therapy market is projected to gather a CAGR of 7.65% based on revenue during the assessed period of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries examined in this
market include:
• The United Kingdom
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
The hormone replacement
therapy market is envisioned to experience growth across the region due to
factors such as a rise in the incidence rate of hormonal disorders among women.
Along with this, the high prevalence of menopausal disorders, coupled with the
increase in the geriatric population suffering from hypothyroidism, are likely
to augment the demand for hormone replacement therapy across, thereby
propelling the hormone replacement therapy market on a growth path.
In Germany, an initiative by
EURORDIS known as the German Network of Pituitary Diseases and Adrenalopathy
was established. Here, the organization’s primary aim is to connect patients
with endocrinologists to address the treatment of diseases caused by hormonal
insufficiencies. Moreover, the network helps in the distribution of guidelines
among patients to educate them about preventive measures. Therefore, such
initiatives are expected to increase the demand for hormone replacement
therapy, simultaneously positioning the German hormone replacement therapy
market on a growth path.
Furthermore, the Women’s
Health Initiative study proved hormone therapy’s efficiency in preventing
fractures related to osteoporosis. This factor primarily supports the market’s
growth in France. Other than this, the health insurance fund in the country
offers reimbursement of almost all medications used for hormone therapy,
thereby driving the hormone replacement therapy market’s development across
France.
Bayer AG is a pharmaceutical
and chemical company specializing in general and specialty medicine. It offers a
wide range of products, such as biotechnology products, agriculture chemicals,
animal and human pharmaceuticals, and other products. Its product portfolio
includes Mirena, which is a hormonal intrauterine device used for long-term
birth control, as well as to treat heavy period flow. Founded in 1863, the
company is headquartered in Leverkusen, Germany.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. EUROPE
HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. EUROPE
HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. EUROPE
HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. EUROPE
HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK
6.1. GERMANY
6.2. FRANCE
6.3. UNITED
KINGDOM
6.4. ITALY
6.5. RUSSIA
6.6. SPAIN
6.7. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE HORMONE REPLACEMENT THERAPY
MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: GERMANY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: FRANCE HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: UNITED KINGDOM HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: ITALY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: RUSSIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: SPAIN HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: REST OF EUROPE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)